Cavities are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
PDB ID | HET | Uniprot Name | EC Number |
---|---|---|---|
1w83 | L11 | Mitogen-activated protein kinase 14 |
PDB ID | HET | Uniprot Name | EC Number | Cavity Similarity |
Align |
---|---|---|---|---|---|
1w83 | L11 | Mitogen-activated protein kinase 14 | / | 1.000 | |
3gcq | 1BU | Mitogen-activated protein kinase 14 | / | 0.537 | |
3hv3 | R49 | Mitogen-activated protein kinase 14 | / | 0.513 | |
2ewa | SB2 | Mitogen-activated protein kinase 14 | / | 0.506 | |
4fk3 | 325 | Serine/threonine-protein kinase B-raf | 2.7.11.1 | 0.506 | |
3l8s | BFF | Mitogen-activated protein kinase 14 | / | 0.502 | |
3njo | PYV | Abscisic acid receptor PYR1 | / | 0.502 | |
4fny | I3K | ALK tyrosine kinase receptor | 2.7.10.1 | 0.502 | |
3qpn | PFK | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.501 | |
3lfe | Z84 | Mitogen-activated protein kinase 14 | / | 0.499 | |
3d7z | GK5 | Mitogen-activated protein kinase 14 | / | 0.497 | |
3o8t | BMU | Mitogen-activated protein kinase 14 | / | 0.492 | |
2ovy | PFJ | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.489 | |
3qpp | PFW | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.488 | |
3b8q | 900 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.487 | |
3prf | FP3 | Serine/threonine-protein kinase B-raf | 2.7.11.1 | 0.484 | |
3ctj | 320 | Hepatocyte growth factor receptor | 2.7.10.1 | 0.483 | |
3p9t | TCL | Repressor | / | 0.483 | |
3sgv | 2BJ | Ditrans,polycis-undecaprenyl-diphosphate synthase ((2E,6E)-farnesyl-diphosphate specific) | 2.5.1.31 | 0.483 | |
5bvw | 1N1 | Epithelial discoidin domain-containing receptor 1 | 2.7.10.1 | 0.480 | |
3eta | 351 | Insulin receptor | 2.7.10.1 | 0.479 | |
4eh6 | 0ON | Mitogen-activated protein kinase 14 | / | 0.478 | |
1rft | PXM | Pyridoxal kinase | 2.7.1.35 | 0.477 | |
4eh7 | 0OO | Mitogen-activated protein kinase 14 | / | 0.476 | |
2jc6 | QPP | Calcium/calmodulin-dependent protein kinase type 1D | 2.7.11.17 | 0.475 | |
4h1j | 0YH | Protein-tyrosine kinase 2-beta | 2.7.10.2 | 0.475 | |
1og5 | SWF | Cytochrome P450 2C9 | / | 0.474 | |
2agv | TG1 | Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 | 3.6.3.8 | 0.474 | |
2ydo | ADN | Adenosine receptor A2a | / | 0.474 | |
2zb4 | 5OP | Prostaglandin reductase 2 | 1.3.1.48 | 0.474 | |
3irm | 1CY | Bifunctional dihydrofolate reductase-thymidylate synthase | 1.5.1.3 | 0.474 | |
2fb8 | 215 | Serine/threonine-protein kinase B-raf | 2.7.11.1 | 0.473 | |
1uwh | BAX | Serine/threonine-protein kinase B-raf | 2.7.11.1 | 0.471 | |
2b36 | 5PP | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.471 | |
2uxu | NAR | HTH-type transcriptional regulator TtgR | / | 0.471 | |
4rh1 | 0TT | Spore photoproduct lyase | / | 0.470 | |
4uug | PXG | Branched-chain amino acid aminotransferase, putative | / | 0.470 | |
4i6h | 1C8 | Serine/threonine-protein kinase PLK2 | 2.7.11.21 | 0.469 | |
3dt1 | P40 | Mitogen-activated protein kinase 14 | / | 0.467 | |
4cjx | 9L9 | C-1-tetrahydrofolate synthase, cytoplasmic, putative | / | 0.465 | |
2uxp | CLM | HTH-type transcriptional regulator TtgR | / | 0.463 | |
3eel | 53T | Uncharacterized protein | / | 0.463 | |
4mvh | 2F5 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.463 | |
3fmk | FMK | Mitogen-activated protein kinase 14 | / | 0.462 | |
2j3j | HC4 | NADPH-dependent oxidoreductase 2-alkenal reductase | 1.3.1.74 | 0.461 | |
2uxh | QUE | HTH-type transcriptional regulator TtgR | / | 0.461 | |
1ly4 | COQ | Dihydrofolate reductase | 1.5.1.3 | 0.460 | |
3fi4 | FI4 | Mitogen-activated protein kinase 14 | / | 0.460 | |
3th8 | TH9 | Ditrans,polycis-undecaprenyl-diphosphate synthase ((2E,6E)-farnesyl-diphosphate specific) | 2.5.1.31 | 0.460 | |
4heu | 15J | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.460 | |
4n3l | 2FN | Prothrombin | 3.4.21.5 | 0.460 | |
4xe6 | 06U | Dihydrofolate reductase | 1.5.1.3 | 0.460 | |
1kij | NOV | DNA gyrase subunit B | / | 0.459 | |
1m13 | HYF | Nuclear receptor subfamily 1 group I member 2 | / | 0.459 | |
1p7t | ACO | Malate synthase G | / | 0.459 | |
2x7h | PFN | Prostaglandin reductase 3 | 1 | 0.459 | |
3oez | STI | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.459 | |
3tub | FPU | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.459 | |
4euf | NAD | Trans-2-enoyl-CoA reductase [NADH] | / | 0.459 | |
1kmv | LII | Dihydrofolate reductase | 1.5.1.3 | 0.458 | |
3flz | FLZ | Mitogen-activated protein kinase 14 | / | 0.458 | |
3vrw | YS5 | Vitamin D3 receptor | / | 0.458 | |
4c1i | EH9 | cGMP-dependent 3',5'-cyclic phosphodiesterase | 3.1.4.17 | 0.458 | |
4qrc | 0LI | Fibroblast growth factor receptor 4 | 2.7.10.1 | 0.458 | |
2oh4 | GIG | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.457 | |
2xkc | 4VQ | Serine/threonine-protein kinase Nek2 | 2.7.11.1 | 0.456 | |
3p3z | P3Z | Putative cytochrome P450 | / | 0.456 | |
4ea1 | 3RX | Dehydrosqualene synthase | / | 0.456 | |
4ehy | ADP | Tetraacyldisaccharide 4'-kinase | / | 0.456 | |
4jbt | ASD | Cytochrome P450 monooxygenase | / | 0.456 | |
4phl | PIL | Phosphodiesterase | / | 0.456 | |
1p91 | SAM | 23S rRNA (guanine(745)-N(1))-methyltransferase | / | 0.455 | |
3hcr | CHD | Ferrochelatase, mitochondrial | 4.99.1.1 | 0.455 | |
4biw | ANP | Sensor histidine kinase CpxA | / | 0.455 | |
4tzt | 468 | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.455 | |
1m78 | CLZ | Dihydrofolate reductase | 1.5.1.3 | 0.454 | |
1vru | AAP | Gag-Pol polyprotein | 2.7.7.49 | 0.454 | |
3eon | 341 | Glutaryl-CoA dehydrogenase | / | 0.454 | |
3qlr | NDP | Dihydrofolate reductase | 1.5.1.3 | 0.454 | |
3vt6 | 5YI | Vitamin D3 receptor | / | 0.454 | |
4eqr | FAD | Coenzyme A disulfide reductase | / | 0.454 | |
4g34 | 924 | Eukaryotic translation initiation factor 2-alpha kinase 3 | 2.7.11.1 | 0.454 | |
4z2t | FAD | 2-hydroxybiphenyl-3-monooxygenase | / | 0.454 | |
1c7o | PPG | Hemolysin | / | 0.453 | |
1dlj | UGA | UDP-glucose 6-dehydrogenase | / | 0.453 | |
1nqu | RDL | 6,7-dimethyl-8-ribityllumazine synthase | 2.5.1.78 | 0.453 | |
1vbi | NAD | Malate/L-lactate dehydrogenase family protein | / | 0.453 | |
1xoq | ROF | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.453 | |
2og8 | 1N8 | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.453 | |
2ops | HBQ | Gag-Pol polyprotein | 2.7.7.49 | 0.453 | |
3ar6 | TG1 | Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 | 3.6.3.8 | 0.453 | |
3itu | IBM | cGMP-dependent 3',5'-cyclic phosphodiesterase | 3.1.4.17 | 0.453 | |
4nb6 | 444 | Nuclear receptor ROR-gamma | / | 0.453 | |
1osv | CHC | Bile acid receptor | / | 0.452 | |
2a59 | LMZ | 6,7-dimethyl-8-ribityllumazine synthase | 2.5.1.78 | 0.452 | |
2b37 | 8PS | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.452 | |
2hb8 | MVD | Vitamin D3 receptor | / | 0.452 | |
2hps | CTZ | Ca2+-triggered coelenterazine-binding protein 1 | / | 0.452 | |
2obx | INI | 6,7-dimethyl-8-ribityllumazine synthase 2 | 2.5.1.78 | 0.452 | |
3fzt | 4JZ | Protein-tyrosine kinase 2-beta | 2.7.10.2 | 0.452 | |
3qm4 | PN0 | Cytochrome P450 2D6 | / | 0.452 | |
4g1n | NZT | Pyruvate kinase PKM | 2.7.1.40 | 0.452 | |
4g31 | 0WH | Eukaryotic translation initiation factor 2-alpha kinase 3 | 2.7.11.1 | 0.452 | |
1ygj | RMC | Pyridoxal kinase | 2.7.1.35 | 0.451 | |
2ydv | NEC | Adenosine receptor A2a | / | 0.451 | |
3cse | N22 | Uncharacterized protein | / | 0.451 | |
3fln | 3FN | Mitogen-activated protein kinase 14 | / | 0.451 | |
4dqu | NAI | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.451 | |
4htx | 19F | cGMP-dependent 3',5'-cyclic phosphodiesterase | 3.1.4.17 | 0.451 | |
4olf | HFG | Proline--tRNA ligase | 6.1.1.15 | 0.451 | |
4yx6 | FMN | Omega-3 polyunsaturated fatty acid synthase subunit PfaD | / | 0.451 | |
1ezf | IN0 | Squalene synthase | 2.5.1.21 | 0.450 | |
2gpv | OHT | Estrogen-related receptor gamma | / | 0.450 | |
2qd5 | CHD | Ferrochelatase, mitochondrial | 4.99.1.1 | 0.450 | |
3l9m | L9M | cAMP-dependent protein kinase catalytic subunit alpha | 2.7.11.11 | 0.450 | |
3tda | PN0 | Cytochrome P450 2D6 | / | 0.450 | |
4j6b | PLO | Cytochrome P450 monooxygenase | / | 0.450 | |
4jln | 18V | Deoxycytidine kinase | 2.7.1.74 | 0.450 | |
5d7p | OCZ | NAD-dependent protein deacetylase sirtuin-2 | 3.5.1 | 0.450 | |
5jtb | ZMA | Adenosine receptor A2a | / | 0.450 | |
1fgi | SU1 | Fibroblast growth factor receptor 1 | / | 0.449 | |
1ouy | 094 | Mitogen-activated protein kinase 14 | / | 0.449 | |
1tbb | ROL | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.449 | |
1tdu | CB3 | Thymidylate synthase | / | 0.449 | |
2zl9 | VDA | Vitamin D3 receptor | / | 0.449 | |
3h3r | 14H | Collagen type IV alpha-3-binding protein | / | 0.449 | |
3irn | 1CY | Bifunctional dihydrofolate reductase-thymidylate synthase | 1.5.1.3 | 0.449 | |
3jw5 | TOP | Dihydrofolate reductase | / | 0.449 | |
3jwc | EKB | Dihydrofolate reductase | / | 0.449 | |
3nrr | D16 | Bifunctional dihydrofolate reductase-thymidylate synthase | / | 0.449 | |
4elg | 52J | Dihydrofolate reductase | / | 0.449 | |
1mkd | ZAR | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.448 | |
1q5d | EPB | Epothilone C/D epoxidase | 1.14 | 0.448 | |
3dfr | MTX | Dihydrofolate reductase | 1.5.1.3 | 0.448 | |
3fmh | 533 | Mitogen-activated protein kinase 14 | / | 0.448 | |
3qly | 55V | Uncharacterized protein | / | 0.448 | |
3vt7 | VDX | Vitamin D3 receptor | / | 0.448 | |
4feu | 537 | Aminoglycoside 3'-phosphotransferase AphA1-IAB | / | 0.448 | |
4kao | KAO | Focal adhesion kinase 1 | 2.7.10.2 | 0.448 | |
4kbn | 25U | Dihydrofolate reductase | 1.5.1.3 | 0.448 | |
5c6c | CMP | cGMP-dependent protein kinase 2 | 2.7.11.12 | 0.448 | |
1n8w | COA | Malate synthase G | / | 0.447 | |
1oj4 | CDM | 4-diphosphocytidyl-2-C-methyl-D-erythritol kinase | 2.7.1.148 | 0.447 | |
1tlc | F89 | Thymidylate synthase | / | 0.447 | |
2w9g | TOP | Dihydrofolate reductase | 1.5.1.3 | 0.447 | |
2zb1 | GK4 | Mitogen-activated protein kinase 14 | / | 0.447 | |
3q0g | BCO | Probable enoyl-CoA hydratase echA8 | 4.2.1.17 | 0.447 | |
4bgi | I4I | Enoyl-[acyl-carrier-protein] reductase [NADH] | 1.3.1.9 | 0.447 | |
4j6d | TES | Cytochrome P450 monooxygenase | / | 0.447 | |
4jv8 | 1M1 | Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta | / | 0.447 | |
3rfm | CFF | Adenosine receptor A2a | / | 0.447 | |
1l2j | ETC | Estrogen receptor beta | / | 0.446 | |
1t9b | 1CS | Acetolactate synthase catalytic subunit, mitochondrial | 2.2.1.6 | 0.446 | |
1tl1 | H18 | Gag-Pol polyprotein | 2.7.7.49 | 0.446 | |
1y60 | H4M | 5,6,7,8-tetrahydromethanopterin hydro-lyase | 4.2.1.147 | 0.446 | |
2i4z | DRH | Peroxisome proliferator-activated receptor gamma | / | 0.446 | |
3h3s | H15 | Collagen type IV alpha-3-binding protein | / | 0.446 | |
3l70 | JZV | Cytochrome b | / | 0.446 | |
3ppk | FNI | Serine/threonine-protein kinase B-raf | 2.7.11.1 | 0.446 | |
3t5i | SER_SER_CMT_FAR | Retinal rod rhodopsin-sensitive cGMP 3',5'-cyclic phosphodiesterase subunit delta | / | 0.446 | |
3vf6 | 0H6 | Glucokinase | 2.7.1.2 | 0.446 | |
3x06 | 5GP | Phosphatidylinositol 5-phosphate 4-kinase type-2 beta | 2.7.1.149 | 0.446 | |
3x2f | NAI | Adenosylhomocysteinase | / | 0.446 | |
4klr | CHD | Ferrochelatase, mitochondrial | 4.99.1.1 | 0.446 | |
4muw | 2F4 | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.446 | |
5iua | 6DX | Adenosine receptor A2a | / | 0.446 | |
2p15 | EZT | Estrogen receptor | / | 0.445 | |
2uxo | TAC | HTH-type transcriptional regulator TtgR | / | 0.445 | |
3e5a | VX6 | Aurora kinase A | 2.7.11.1 | 0.445 | |
3eg5 | GNP | Cell division control protein 42 homolog | / | 0.445 | |
3qlx | QLR | Uncharacterized protein | / | 0.445 | |
4aql | TXC | Guanine deaminase | 3.5.4.3 | 0.445 | |
4fgh | 0U6 | Dihydrofolate reductase | 1.5.1.3 | 0.445 | |
5i2h | AGI | O-methyltransferase family 2 | / | 0.445 | |
3eml | ZMA | Adenosine receptor A2a | / | 0.445 | |
1eji | THF | Serine hydroxymethyltransferase, cytosolic | / | 0.444 | |
1ly3 | COG | Dihydrofolate reductase | 1.5.1.3 | 0.444 | |
2prh | 238 | Dihydroorotate dehydrogenase (quinone), mitochondrial | 1.3.5.2 | 0.444 | |
2uxi | G50 | HTH-type transcriptional regulator TtgR | / | 0.444 | |
3cth | 319 | Hepatocyte growth factor receptor | 2.7.10.1 | 0.444 | |
3d74 | NBB | Pheromone-binding protein ASP1 | / | 0.444 | |
3g4g | D71 | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | 3.1.4.53 | 0.444 | |
3gwf | FAD | Cyclohexanone monooxygenase | / | 0.444 | |
3kjs | DQ1 | Bifunctional dihydrofolate reductase-thymidylate synthase | / | 0.444 | |
3qlz | QLZ | Uncharacterized protein | / | 0.444 | |
3srq | Q19 | Dihydrofolate reductase | 1.5.1.3 | 0.444 | |
3uzw | NAP | 3-oxo-5-beta-steroid 4-dehydrogenase | / | 0.444 | |
4a4l | 939 | Serine/threonine-protein kinase PLK1 | 2.7.11.21 | 0.444 | |
4bbx | LKF | cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A | 3.1.4.17 | 0.444 | |
4i6f | 1C7 | Serine/threonine-protein kinase PLK2 | 2.7.11.21 | 0.444 | |
4iaq | 2GM | 5-hydroxytryptamine receptor 1B | / | 0.444 | |
4y6n | UPG | Glucosyl-3-phosphoglycerate synthase | 2.4.1.266 | 0.444 | |
3rey | XAC | Adenosine receptor A2a | / | 0.444 | |
1cbr | REA | Cellular retinoic acid-binding protein 1 | / | 0.443 | |
1iep | STI | Tyrosine-protein kinase ABL1 | 2.7.10.2 | 0.443 | |
1pkf | EPD | Epothilone C/D epoxidase | 1.14 | 0.443 | |
2c9e | PID | Peridinin-chlorophyll a protein, high-salt form | / | 0.443 | |
2e9a | B28 | Ditrans,polycis-undecaprenyl-diphosphate synthase ((2E,6E)-farnesyl-diphosphate specific) | 2.5.1.31 | 0.443 | |
3ar7 | TG1 | Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 | 3.6.3.8 | 0.443 | |
3ds6 | A17 | Mitogen-activated protein kinase 14 | / | 0.443 | |
3fko | FKO | Mitogen-activated protein kinase 14 | / | 0.443 | |
3fyw | XCF | Dihydrofolate reductase | 1.5.1.3 | 0.443 | |
3htj | ET | EbrA repressor | / | 0.443 | |
3oct | 1N1 | Tyrosine-protein kinase BTK | 2.7.10.2 | 0.443 | |
3td8 | D2R | Dihydrofolate reductase | 1.5.1.3 | 0.443 | |
3uwl | FOZ | Thymidylate synthase | / | 0.443 | |
3vo3 | 0KF | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.443 | |
4a87 | NAR | Major pollen allergen Bet v 1-A | / | 0.443 | |
4bew | CZA | Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 | 3.6.3.8 | 0.443 | |
4ec3 | REN | Reticuline oxidase | 1.21.3.3 | 0.443 | |
4l17 | DNQ | Glutamate receptor 2 | / | 0.443 | |
4nmc | FAD | Bifunctional protein PutA | / | 0.443 | |
1ia4 | TQ6 | Dihydrofolate reductase | 1.5.1.3 | 0.442 | |
1tkz | H16 | Gag-Pol polyprotein | 2.7.7.49 | 0.442 | |
3aba | FLI | Cytochrome P450 | / | 0.442 | |
3ar4 | TG1 | Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 | 3.6.3.8 | 0.442 | |
3frd | DHF | Dihydrofolate reductase | 1.5.1.3 | 0.442 | |
3hbf | MYC | Flavonoid 3-O-glucosyltransferase | 2.4.1 | 0.442 | |
3qbw | ADP | Anhydro-N-acetylmuramic acid kinase | / | 0.442 | |
3qj5 | 022 | Alcohol dehydrogenase class-3 | 1.1.1.1 | 0.442 | |
3sru | Q26 | Dihydrofolate reductase | 1.5.1.3 | 0.442 | |
4eev | L1X | Hepatocyte growth factor receptor | 2.7.10.1 | 0.442 | |
4eyj | N61 | Mitogen-activated protein kinase 13 | 2.7.11.24 | 0.442 | |
4fhf | 0TT | Spore photoproduct lyase | / | 0.442 | |
1d3h | A26 | Dihydroorotate dehydrogenase (quinone), mitochondrial | 1.3.5.2 | 0.441 | |
2cl5 | BIE | Catechol O-methyltransferase | 2.1.1.6 | 0.441 | |
2ilt | NN1 | Corticosteroid 11-beta-dehydrogenase isozyme 1 | 1.1.1.146 | 0.441 | |
3fmm | XI2 | Mitogen-activated protein kinase 14 | / | 0.441 | |
3gyt | DL4 | Nuclear hormone receptor of the steroid/thyroid hormone receptors superfamily | / | 0.441 | |
3nx4 | NAP | Putative oxidoreductase | / | 0.441 | |
3saz | 043 | Malate synthase G | / | 0.441 | |
3vjc | ZGA | Squalene synthase | 2.5.1.21 | 0.441 | |
3vt3 | VDX | Vitamin D3 receptor | / | 0.441 | |
3wsb | RWZ | Farnesyltransferase, putative | / | 0.441 | |
3znq | SS8 | D-amino-acid oxidase | 1.4.3.3 | 0.441 | |
4a32 | 2CD | Glycylpeptide N-tetradecanoyltransferase | / | 0.441 | |
4at0 | FAD | Possible succinate dehydrogenase | / | 0.441 | |
4elb | 34S | Dihydrofolate reductase | / | 0.441 | |
1ex7 | 5GP | Guanylate kinase | 2.7.4.8 | 0.440 | |
1vj3 | TAB | Dihydrofolate reductase | 1.5.1.3 | 0.440 | |
1zzl | TZY | Mitogen-activated protein kinase 14 | / | 0.440 | |
3e92 | G6A | Mitogen-activated protein kinase 14 | / | 0.440 | |
3fhx | PXL | Pyridoxal kinase | 2.7.1.35 | 0.440 | |
3ozd | 4CT | S-methyl-5'-thioadenosine phosphorylase | / | 0.440 | |
3vsp | EK8 | Peroxisome proliferator-activated receptor gamma | / | 0.440 | |
3vtd | TKD | Vitamin D3 receptor | / | 0.440 | |
3x04 | GNP | Phosphatidylinositol 5-phosphate 4-kinase type-2 beta | 2.7.1.149 | 0.440 | |
4ele | 31I | Dihydrofolate reductase | / | 0.440 | |
4h96 | 14Q | Dihydrofolate reductase | 1.5.1.3 | 0.440 | |
4pd6 | URI | Nucleoside permease | / | 0.440 | |
5uvi | ZMA | Adenosine receptor A2a | / | 0.440 | |
5k2d | ZMA | Adenosine receptor A2a | / | 0.440 |